Vimarsana
Biggest News Aggregation in the World

Page 7 - Pharma Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Pharma Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Pharma Inc Today - Breaking & Trending Today

StockNews.com Begins Coverage on IGC Pharma (NYSEAMERICAN:IGC) - Vimarsana News

StockNews.com Begins Coverage on IGC Pharma (NYSEAMERICAN:IGC)

StockNews.com began coverage on shares of IGC Pharma (NYSEAMERICAN:IGC – Free Report) in a research report report published on Tuesday. The firm issued a sell rating on the construction company’s stock. IGC Pharma Stock Performance IGC stock opened at $0.51 on Tuesday. The stock has a market capitalization of $34.15 million, a price-to-earnings ratio of […]

Acasti Pharma (NASDAQ:ACST) Stock Passes Above Two Hundred Day Moving Average of $2.75 - Vimarsana News

Acasti Pharma (NASDAQ:ACST) Stock Passes Above Two Hundred Day Moving Average of $2.75

Acasti Pharma Inc. (NASDAQ:ACST – Get Free Report) shares crossed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $2.75 and traded as high as $3.08. Acasti Pharma shares last traded at $2.96, with a volume of 13,180 shares trading hands. Analyst Ratings Changes Separately, Craig […]

MEI Pharma (NASDAQ:MEIP) Research Coverage Started at StockNews.com - Vimarsana News

MEI Pharma (NASDAQ:MEIP) Research Coverage Started at StockNews.com

StockNews.com began coverage on shares of MEI Pharma (NASDAQ:MEIP – Free Report) in a research note released on Monday. The firm issued a buy rating on the stock. MEIP has been the topic of a number of other reports. TheStreet lowered MEI Pharma from a c- rating to a d+ rating in a research report […]

MEI Pharma (NASDAQ:MEIP) Coverage Initiated by Analysts at StockNews.com - Vimarsana News

MEI Pharma (NASDAQ:MEIP) Coverage Initiated by Analysts at StockNews.com

StockNews.com assumed coverage on shares of MEI Pharma (NASDAQ:MEIP – Get Free Report) in a note issued to investors on Monday. The firm set a “buy” rating on the stock. A number of other equities analysts have also recently issued reports on MEIP. Stifel Nicolaus reiterated a “hold” rating and issued a $7.00 price target […]

Source: wkrb13.com
Short Interest in FSD Pharma Inc. (NASDAQ:HUGE) Grows By 12.2% - Vimarsana News

Short Interest in FSD Pharma Inc. (NASDAQ:HUGE) Grows By 12.2%

FSD Pharma Inc. (NASDAQ:HUGE – Get Free Report) saw a significant increase in short interest during the month of April. As of April 15th, there was short interest totalling 374,000 shares, an increase of 12.2% from the March 31st total of 333,400 shares. Based on an average daily trading volume, of 149,300 shares, the short-interest […]

Source: wkrb13.com